INOVIO PHARMACEUTICALS, INC. Business Operations Contracts & Agreements
16 Contracts & Agreements
- Collaboration Agreements (7 contracts)
- Indemnification Agreements (1)
- Sales Agreements (6)
- Termination Agreements (1)
- Voting Agreements (1)
- First Amendment to the Amended and Restated License and Collaboration Agreement, dated June 14, 2023, by and between Inovio Pharmaceuticals, Inc. and Beijing Apollo Saturn... (Filed With SEC on March 6, 2024)
- ATM Equity OfferingSM Sales Agreement dated November 9, 2021 by and among Inovio Pharmaceuticals, Inc., BofA Securities, Inc., RBC Capital Markets, LLC and Oppenheimer & Co. Inc (Filed With SEC on November 9, 2021)
- Amended and Restated Collaboration and License Agreement dated June 7, 2021, by and between Inovio Pharmaceuticals, Inc. and Advaccine Biopharmaceuticals Suzhou Co., Ltd (Filed With SEC on August 9, 2021)
- Collaboration and License Agreement dated December 31, 2020 between Inovio Pharmaceuticals, Inc. and Advaccine Biopharmaceuticals Suzhou Co., Ltd (Filed With SEC on March 1, 2021)
- At-The-Market Equity Offering Sales Agreement dated April 3, 2020 between Inovio Pharmaceuticals, Inc. and Stifel, Nicolaus & Company, Incorporated (Filed With SEC on April 3, 2020)
- Amendment No. 2 to the At-The-Market Equity Offering Sales Agreement dated March 9, 2020 between Inovio Pharmaceuticals, Inc. and Stifel, Nicolaus & Company, Incorporated (Filed With SEC on March 9, 2020)
- Amendment No. 1 to the At-The-Market Equity Offering Sales Agreement dated February 7, 2020 between Inovio Pharmaceuticals, Inc. and Stifel, Nicolaus & Company, Incorporated (Filed With SEC on February 7, 2020)
- At-the-Market Equity Offering Sales Agreement dated May 25, 2018 between Inovio Pharmaceuticals, Inc. and Stifel, Nicolaus & Company, Incorporated (Filed With SEC on May 25, 2018)
- Amended and Restated License and Collaboration Agreement, dated December 29, 2017, by and between Inovio Pharmaceuticals, Inc. and Beijing Apollo Saturn Biological Technology... (Filed With SEC on March 14, 2018)
- DNA CANCER VACCINE COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on November 9, 2015)
- TERMINATION OF VOTING TRUST AGREEMENT (Filed With SEC on November 12, 2013)
- Collaboration, Option and License Agreement (Filed With SEC on September 12, 2013)
- INOVIO PHARMACEUTICALS, INC. $25,000,000 SALES AGREEMENT (Filed With SEC on June 1, 2012)
- INDEMNIFICATION AGREEMENT (Filed With SEC on August 19, 2009)
- INOVIO BIOMEDICAL CORPORATION VOTING TRUST AGREEMENT (Filed With SEC on June 2, 2009)
- [Confidential Portions Omitted] NON-EXCLUSIVE LICENSE AND RESEARCH COLLABORATION AGREEMENT by and between MERCK & CO., INC. and GENETRONICSBIOMEDICAL CORPORATION and... (Filed With SEC on August 13, 2004)